ClearBridge LLC (Maryland)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-348,128
Closed -$16.3K 172
2018
Q2
$16.3K Buy
348,128
+61,630
+22% +$2.55M 0.27% 92
2018
Q1
$10.2M Sell
286,498
-3,570
-1% -$140K 0.23% 122
2017
Q4
$12.6M Buy
290,068
+134,050
+86% +$6.26M 0.26% 105
2017
Q3
$8.16M Buy
156,018
+12,260
+9% +$684K 0.18% 124
2017
Q2
$8.41M Hold
143,758
0.18% 120
2017
Q1
$6.59M Buy
143,758
+400
+0.3% +$19.9K 0.14% 125
2016
Q4
$7.54M Buy
143,358
+26,600
+23% +$1.29M 0.17% 119
2016
Q3
$5.21M Hold
116,758
0.1% 122
2016
Q2
$4.45M Buy
116,758
+5,410
+5% +$238K 0.09% 122
2016
Q1
$4.59M Buy
+111,348
New +$4.59M 0.09% 119

Other funds holding SYNH

ClearBridge LLC (Maryland)'s SYNH Position: Q3 2018 in Review

ClearBridge LLC (Maryland) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2018, closing a stake of 348,128 shares — an estimated $16.3K sold.

ClearBridge LLC (Maryland) first reported a position in SYNH in Q1 2016 and held it in 10 quarters. The position peaked at $12.6M in Q4 2017. 240 funds tracked by Wall St. Rank hold SYNH as of Q3 2018.

  • ClearBridge LLC (Maryland) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2018 after selling out during the quarter.
  • ClearBridge LLC (Maryland) sold 348,128 Syneos Health, Inc. Class A Common Stock shares in Q3 2018, an estimated $16.3K.
  • ClearBridge LLC (Maryland) first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 10 quarters.
  • ClearBridge LLC (Maryland)'s Syneos Health, Inc. Class A Common Stock position peaked at $12.6M in Q4 2017.
  • 240 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q3 2018, filed 14 Nov 2018.